THE LORNET STUDY IN RUSSIAN FEDERATION: THE SAFETY OF TOCILIZUMAB IN THE TREATMENT MODERATE AND SEVERE RHEUMATOID ARTHRITIS

被引:0
|
作者
Panasynk, E. [1 ]
Nasonov, E. [1 ]
机构
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
关键词
D O I
10.1136/annrheumdis-2014-eular.3590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0425
引用
收藏
页码:947 / 948
页数:2
相关论文
共 50 条
  • [21] The Safety and Efficacy Of Tocilizumab Subcutaneous In Combination With Traditional Dmards In Patients With Moderate To Severe Rheumatoid Arthritis Up To 48 Weeks (BREVACTA).
    Kivitz, Alan
    Olech, Ewa
    Borofsky, Michael A.
    Zazueta, Beatriz M.
    Navarro-Sarabia, Federico
    Radominski, Sebastiao C.
    Merrill, Joan T.
    Wells, Chris
    Wimalasundera, Sunethra
    Douglass, Wendy
    Pope, Janet E.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S604 - S605
  • [22] Tocilizumab in the treatment of rheumatoid arthritis and beyond
    Shetty, Anjali
    Hanson, Rebekah
    Korsten, Peter
    Shawagfeh, Munir
    Arami, Shiva
    Volkov, Suncica
    Vila, Olga
    Swedler, William
    Shunaigat, Abdel Naser
    Smadi, Sameer
    Sawaqed, Ray
    Perkins, David
    Shahrara, Shiva
    Sweiss, Nadera J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 349 - 364
  • [23] RITUXIMAB AND TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Gonzalez-Vacarezza, Nicolas
    Aleman, Alicia
    Gonzalez, Graciela
    Perez, Ana
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (03) : 282 - 288
  • [24] Subcutaneous tocilizumab for the treatment of rheumatoid arthritis
    Mitchell, Emma
    Jones, Graeme
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (02) : 103 - 114
  • [25] Tocilizumab in the treatment of adult rheumatoid arthritis
    Sanmarti, Raimon
    Ruiz-Esquide, Virginia
    Bastida, Carla
    Soy, Dolor
    IMMUNOTHERAPY, 2018, 10 (06) : 447 - 464
  • [26] Review of tocilizumab in the treatment of rheumatoid arthritis
    Okuda, Yasuaki
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 75 - 82
  • [27] Safety and Efficacy of Baricitinib in Elderly Patients with Moderate to Severe Rheumatoid Arthritis
    Fleischmann, Roy
    Alam, Jahangir
    Arora, Vipin
    Bradley, John D.
    Schlichting, Douglas E.
    Muram, David
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] IMPACT OF CONCOMITANT METHOTREXATE DOSE ON THE EFFICACY AND SAFETY OF SARILUMAB FOR TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: THE MOBILITY STUDY
    Huizinga, T. W. J.
    Yazici, Y.
    Thompson, D.
    Decktor, D. L.
    Fan, C.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 491 - 492
  • [29] Abatacept: A novel treatment for moderate-to-severe rheumatoid arthritis
    Reynolds, Jennifer
    Shojania, Kam
    Marra, Carlo A.
    PHARMACOTHERAPY, 2007, 27 (12): : 1693 - 1701
  • [30] SAFETY OF TOCILIZUMAB THERAPY IN HBSAG CARRIERS WITH RHEUMATOID ARTHRITIS: A PROSPECTIVE STUDY
    Fang, L.
    Liao, Z.
    Lin, Z.
    Jin, O.
    Pan, Y.
    Gu, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 485 - 485